22nd Century Group Reports Third Quarter 2025 Financial Results
1. XXII is now debt-free with a strong financial position after $9.5M insurance settlement. 2. The company is pivoting to a branded product strategy, expanding VLN® distribution. 3. Sales decreased slightly to $4.0M but consolidated net income rose to $5.5M. 4. New low-nicotine products align with FDA mandates, enhancing market potential. 5. Recent product shipments to top retailers mark a significant expansion phase.